News – Page 3 – www.brainwork.md

29th October 2021

Getting the complete clinical picture: A closer look at smouldering MS

https://www.brainwork.md/content/uploads/2021/10/MPR919-Brainwork-ECTRIMS-Illustrations-V00-05-20211012_illustration-02_inflammation-.png 6641 3734 Howard Donohue, PhD Howard Donohue, PhD https://secure.gravatar.com/avatar/7d0af6ce1f456871ef502d2e984812d6?s=96&d=mm&r=g 29th October 2021 24th January 2022

Multiple sclerosis (MS) is an inflammatory disease that is often dominated by relapsing-remitting symptoms.1 However, inflammation is not only present in acute and relapsing MS, but also in the secondary…

Howard Donohue, PhD
0
0

29th October 2021

Expanded interval dosing of natalizumab: Outcomes from the NOVA study

https://www.brainwork.md/content/uploads/2021/10/MPR919-Brainwork-ECTRIMS-Illustrations-V00-05-20211012_illustration-04_antibody.png 6641 3734 Howard Donohue, PhD Howard Donohue, PhD https://secure.gravatar.com/avatar/7d0af6ce1f456871ef502d2e984812d6?s=96&d=mm&r=g 29th October 2021 1st November 2021

Natalizumab 300 mg every 4 weeks (Q4W) is approved for the treatment of relapsing-remitting multiple sclerosis (MS). In patients previously exposed to the JC virus, natalizumab is associated with a…

Howard Donohue, PhD
0
0

29th October 2021

Aquaporin-4-positive neuromyelitis optica spectrum disorder: A favourable long-term benefit-risk profile of eculizumab treatment

https://www.brainwork.md/content/uploads/2021/10/MPR919-Brainwork-ECTRIMS-Illustrations-V00-06-20211013_illustration-05_nerve.png 6641 3734 Howard Donohue, PhD Howard Donohue, PhD https://secure.gravatar.com/avatar/7d0af6ce1f456871ef502d2e984812d6?s=96&d=mm&r=g 29th October 2021 1st November 2021

Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease that typically affects the optic nerves and spinal cord.1,2 At least two-thirds of cases are associated with aquaporin-4 (AQP4) antibodies…

Howard Donohue, PhD
0
0

22nd October 2021

Integrative medicine for multiple sclerosis: Outcomes from the Inspire MS program

https://www.brainwork.md/content/uploads/2021/10/MPR919-Brainwork-ECTRIMS-Illustrations-V00-06-20211019_illustration-01_Wellness.png 5692 3201 Howard Donohue, PhD Howard Donohue, PhD https://secure.gravatar.com/avatar/7d0af6ce1f456871ef502d2e984812d6?s=96&d=mm&r=g 22nd October 2021 29th October 2021

A growing body of evidence suggests that integrative medicine (IM) modalities can enhance the comprehensive care of patients with multiple sclerosis (MS). Thirty to eighty percent of patients with MS…

Howard Donohue, PhD
0
0

20th October 2021

To stay or to switch? Assessing long-term treatment outcomes and impact of treatment on patients’ quality of life

https://www.brainwork.md/content/uploads/2021/10/MPR919-Brainwork-ECTRIMS-Illustrations-V00-05-20211012_illustration-03_stay_or_switch.png 6641 3734 Howard Donohue, PhD Howard Donohue, PhD https://secure.gravatar.com/avatar/7d0af6ce1f456871ef502d2e984812d6?s=96&d=mm&r=g 20th October 2021 29th October 2021

The main concerns of patients, regarding their treatment, include disease control and safety, but they also want to make sure that their day-to-day life remains as close to normal as…

Howard Donohue, PhD
0
0

8th October 2021

Speaking to Prof. Barbara Tettenborn – “You have to love what you do, otherwise you are not good”

https://www.brainwork.md/content/uploads/2021/10/Brainwork-Prof-Barbara-Tettenborn-Interview-1.jpg 1500 1001 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 8th October 2021 1st November 2021

Prof. Barbara Tettenborn is the chief of the Department of Neurology at the Cantonal Hospital St. Gallen, Switzerland since 1999. In addition to her position at the hospital, she is…

Anna Stelling, PhD
0
0

20th September 2021

New guidelines for the use of MRI in patients with multiple sclerosis

https://www.brainwork.md/content/uploads/2021/09/Brainwork-New-guidelines-for-the-use-of-MRI-in-patients-with-multiple-sclerosis.jpg 1000 665 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 20th September 2021 1st November 2021

Magnetic resonance imaging (MRI) in patients with multiple sclerosis (MS) is a well-established tool for diagnostic, prognostic and disease monitoring purposes.1 Its use has been specified in various guideline papers…

Anna Stelling, PhD
0
0

26th August 2021

The female stroke: Sex differences affect stroke presentation and management

https://www.brainwork.md/content/uploads/2021/08/Brainwork-Stroke-Summer-School-2-Stroke-in-women-V00-01-20210825.png 1000 562 Shawn Haigh Shawn Haigh https://secure.gravatar.com/avatar/d4448de12cafdc782da0f7b369642f0e?s=96&d=mm&r=g 26th August 2021 26th August 2021

Women have a unique experience when it comes to stroke. Several differences between the sexes exist in stroke; in the epidemiology of the disease, clinical presentation, medical care and patient…

Shawn Haigh
0
0

26th August 2021

Dopamine in stroke rehabilitation – Where do we stand?

https://www.brainwork.md/content/uploads/2021/08/Brainwork-Stroke-Summer-School-1-Dopamine-in-stroke-rehabilitation-V00-01-20210819.png 1000 562 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 26th August 2021 26th August 2021

During this year’s “Stroke Summer School 2021” in Basel, Switzerland, Stefan Engelter (Stroke Unit, University Hospital Basel, Switzerland) provided an overview of what is known about the use of dopamine…

Anna Stelling, PhD
0
0

20th August 2021

Lipids and stroke: An update

https://www.brainwork.md/content/uploads/2021/08/MPR919-Brainwork-Stroke-Summer-School-3-Lipids-and-stroke-V00-01-20210819.png 950 535 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 20th August 2021 20th August 2021

During this year’s “Stroke Summer School 2021” in Basel, Switzerland, Gian Marco De Marchis (Stroke Unit, University Hospital Basel, Switzerland) provided an overview of the most important recent findings regarding…

Anna Stelling, PhD
0
1